# Divalproex Sodium ER in Adult Autism

> **NCT00211796** · PHASE4 · COMPLETED · sponsor: **Montefiore Medical Center** · enrollment: 10 (estimated)

## Conditions studied

- Autism

## Interventions

- **DRUG:** Divalproex Sodium ER

## Key facts

- **NCT ID:** NCT00211796
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2018-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00211796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00211796, "Divalproex Sodium ER in Adult Autism". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00211796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*